These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4029996)

  • 1. Acute effect of sublingual nifedipine on right ventricular systolic time intervals in primary pulmonary hypertension--an echocardiographic study.
    Wasir HS; Mohan JC; Bhatia ML
    Indian Heart J; 1985; 37(2):78-81. PubMed ID: 4029996
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of acute effects of sublingual nifedipine and oral diltiazem by echocardiographic right ventricular systolic time intervals in primary pulmonary hypertension.
    Mishra M; Kumar N; Thakur R; Bhandari K; Puri VK
    Indian Heart J; 1986; 38(3):198-201. PubMed ID: 3557521
    [No Abstract]   [Full Text] [Related]  

  • 3. M-mode echocardiographic assessment of the effect of nifedipine on left ventricular function in patients with congestive heart failure.
    Sood AK; Wasir HS; Kasliwal RR; Khanna AR
    Indian Heart J; 1984; 36(1):15-9. PubMed ID: 6706360
    [No Abstract]   [Full Text] [Related]  

  • 4. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
    Rubin LJ
    Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
    [No Abstract]   [Full Text] [Related]  

  • 6. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A; Philip-Joet F; Guintoli A; Torresani J; Arnaud A
    Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Echocardiographic study of right ventricular performance by acute and chronic pressure overloadings].
    Tanimoto M; Iwasaki T; Yamamoto T; Makihata S; Konishiike A; Mihata S; Kawakita S; Yamasaki K; Yasutomi N; Kawai Y
    J Cardiogr; 1984 Aug; 14(2):403-14. PubMed ID: 6533200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.
    Haché M; Denault A; Bélisle S; Robitaille D; Couture P; Sheridan P; Pellerin M; Babin D; Noël N; Guertin MC; Martineau R; Dupuis J
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):642-9. PubMed ID: 12658208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of sublingual nifedipine in patients with ischemic heart disease and depressed left ventricular function.
    Losardo AA; Klein NA; Beer N; Strom JA; Wexler JP; Sonnenblick EH; Frishman WH
    Angiology; 1982 Dec; 33(12):811-7. PubMed ID: 7181173
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute effect of sublingual nifedipine on right and left ventricular function in patients with chronic cor pulmonale.
    Wasir HS; Hariharan V; Malhotra A; Gopinath P
    J Assoc Physicians India; 1986 Nov; 34(11):769-71. PubMed ID: 3558297
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S; Salvi A; Fioretti P; Camerini F
    G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effect of sublingual nifedipine in patients with congestive heart failure.
    Wasir HS; Sood AK
    Indian Heart J; 1984; 36(1):8-14. PubMed ID: 6706374
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Tei index with invasive measurements of right ventricular function.
    Grignola JC; Ginés F; Guzzo D
    Int J Cardiol; 2006 Oct; 113(1):25-33. PubMed ID: 16325940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echocardiographic study in pulmonary hypertension].
    Frídl P; Niederle P; Widimský J; Riedel M; Jandová R; Jebavý P
    Cas Lek Cesk; 1983 Jun; 122(23):712-6. PubMed ID: 6871956
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic evaluation of nifedipine in primary pulmonary hypertension--short and long term effects].
    Yamaguchi S; Tsuiki K; Hayasaka M; Oguma M; Ohta I; Kaminishi T; Sukekawa H; Kanaya T; Yasui S
    Kokyu To Junkan; 1986 Feb; 34(2):171-6. PubMed ID: 3704359
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of primary pulmonary hypertension with nifedipine. A hemodynamic and scintigraphic evaluation.
    Rubin LJ; Nicod P; Hillis LD; Firth BG
    Ann Intern Med; 1983 Oct; 99(4):433-8. PubMed ID: 6625374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Noninvasive evaluation of the effectiveness of the treatment of primary pulmonary hypertension. Case report].
    Paczek A; Rydlewska-Sadowska W
    Kardiol Pol; 1987; 30(12):791-7. PubMed ID: 3452680
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose inhalation therapy with nitric oxide and oxygen--implications for long-term application in patients with COPD and pulmonary hypertension.
    Leitner C; Ziesche R; Zimpfer M; Block LH; Germann P
    Acta Anaesthesiol Scand Suppl; 1996; 109():96-7. PubMed ID: 8901962
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nifedipine on systemic and pulmonary vascular impedance in subjects undergoing cardiac catheterization.
    Noda T; Yaginuma T; O'Rourke MF; Hosoda S
    Hypertens Res; 2006 Jul; 29(7):505-13. PubMed ID: 17044663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.